ARCHIVES

FDA Approves Novartis Drug Zometa For Multiple Myeloma And Bone Mets.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Acting NIH Director Says M.D. Anderson President John Mendelsohn Outlines 10-Point Plan For Cancer Research

February 20, 2009

Kulig Will Oversee Outcomes Research at NCCN

September 30, 2011

DCT Advisors Approve Increased Spending On Trials Monitoring

May 6, 1994

Obituary: Martin Abeloff, 65, Cancer Center Director At Johns Hopkins.

September 21, 2007

Unclear Whether Insurance Will Cover AACR Losses

April 25, 2003

AACR Presents 2014 Awards, Arteaga Becomes President at Annual Meeting

April 11, 2014